Advertisement
Canada markets open in 2 hours 41 minutes

  • S&P/TSX

    22,375.83
    +116.63 (+0.52%)
     

  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     

  • DOW

    39,387.76
    +331.36 (+0.85%)
     

  • CAD/USD

    0.7309
    -0.0002 (-0.03%)
     

  • CRUDE OIL

    79.89
    +0.63 (+0.79%)
     

  • Bitcoin CAD

    86,200.46
    +2,603.68 (+3.11%)
     

  • CMC Crypto 200

    1,305.53
    -52.48 (-3.86%)
     

  • GOLD FUTURES

    2,383.90
    +43.60 (+1.86%)
     

  • RUSSELL 2000

    2,073.63
    +18.49 (+0.90%)
     

  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     

  • NASDAQ futures

    18,296.25
    +81.75 (+0.45%)
     

  • VOLATILITY

    12.78
    +0.09 (+0.71%)
     

  • FTSE

    8,451.18
    +69.83 (+0.83%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6778
    0.0000 (0.00%)
     

Sensex edges up but caution prevails ahead of Fed comments

Reuters
Brokers trade at their computer terminals at a stock brokerage firm in Mumbai, India, February 17, 2016. REUTERS/Shailesh Andrade/Files

(Reuters) - Indian shares closed slightly higher on Wednesday, led by drug maker Aurobindo Pharma Ltd (ARBN.NS) after stellar quarterly results, but sentiment remained edgy as investors awaited further cues on whether the U.S. Federal Reserve will raise interest rates this year.

The benchmark BSE Sensex (.BSESN) closed 0.25 percent higher at 28,059.94, while the broader NSE Nifty (.NSEI) ended up 0.21 percent at 8,650.30.

Aurobindo Pharma jumped 7 percent after the company on Tuesday reported a 24 percent rise in its June-quarter consolidated profit, boosted by higher sales.

(Reporting by Aastha Agnihotri in Bengaluru; Editing by Amrutha Gayathri)